PharmaShots | Incisive News in 3 Shots

Subscribe Now

Astrazeneca

AstraZeneca Reports the Data from PURSUIT P-IIb Study Evaluating AZD0780

AstraZeneca Reports the Data from PURSUIT P-IIb Study Evaluating AZD0780

April 1, 2025

AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Receives the CHMP’s Positive Opinion for 1L Mantle Cell Lymphoma (MCL)

AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Receives the CHMP’s Positive Opinion for 1L Mantle Cell Lymphoma (...

March 31, 2025

AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

March 25, 2025

AstraZeneca Collaborates with Syneron Bio to Develop Macrocyclic Peptides for Chronic Diseases

AstraZeneca Collaborates with Syneron Bio to Develop Macrocyclic Peptides for Chronic Diseases

March 24, 2025

AstraZeneca Reports P-III (CALYPSO) Trial Data of Eneboparatide for Chronic Hypoparathyroidism (HypoPT)

AstraZeneca Reports P-III (CALYPSO) Trial Data of Eneboparatide for Chronic Hypoparathyroidism (HypoPT)

March 19, 2025

AstraZeneca to acquire EsoBiotec for ~$1B

AstraZeneca to acquire EsoBiotec for ~$1B

March 18, 2025

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us